Skip to main content
梓橦宫 logo

梓橦宫 — Investor Relations & Filings

Ticker · 920566 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 625 across all filing types
Latest filing 2023-12-10 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920566

About 梓橦宫

http://www.zitonggong.com/

Zitonggong specializes in the research, development, and production of specialized therapeutic agents. Established with a heritage dating back to 1780, the company holds a recognized heritage brand designation. Its primary product portfolio centers on neurological and cerebrovascular health, featuring Oxiracetam in various dosage forms for treating cognitive dysfunction and brain injuries. The company also develops treatments for digestive health, including Compound Aloe Capsules, and produces artificial Oriental Bezoar. Operations are centered on integrating traditional medicinal knowledge with modern chemical synthesis and manufacturing standards. The company maintains a focus on clinical efficacy and technological advancement in the fields of neurology and gastroenterology.

Recent filings

Filing Released Lang Actions
独立董事提名人声明与承诺
Board/Management Information Classification · 95% confidence The document is a nomination statement and declaration for independent director candidates of Sichuan Zitonggong Pharmaceutical Co., Ltd. It details the qualifications, independence criteria, and legal compliance of the nominees. There is no financial data, no report or results announcement, no voting results, no management changes announcement, and no regulatory certification. The document is a formal announcement related to board/management information, specifically about director nominations. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not a report publication or certification, so it is not RPA or RNS.
2023-12-10 Chinese
第三届董事会第二十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 25th meeting of the third board of directors of Sichuan Zitonggong Pharmaceutical Co., Ltd. It includes information about board member nominations, audit firm reappointment, amendments to internal governance documents, and plans for a shareholder meeting. The content focuses on board and management changes, governance matters, and related approvals. It is not a full annual report, audit report, or financial statement. It is not a call transcript or earnings release. The document is a formal announcement of board meeting decisions, which fits the category of Board/Management Information (MANG). The document length is about 4,883 characters, which is sufficient for a detailed board meeting resolution announcement. Therefore, the appropriate classification is MANG with high confidence.
2023-12-10 Chinese
关于使用部分闲置募集资金购买理财产品的进展公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from a company about the progress of using idle raised funds to purchase financial products. It includes specifics about the amounts, types of financial products, expected returns, risk controls, and compliance with stock exchange rules. The document is not a full financial report, earnings release, or management discussion, but rather a regulatory disclosure about capital usage and investment activities. It fits the category of Capital/Financing Update (CAP) because it updates shareholders and the market on the company's financing activities related to the use of raised funds for financial product investments.
2023-12-10 Chinese
独立董事候选人声明与承诺（程志鹏）
Board/Management Information Classification · 95% confidence The document is a declaration and commitment statement by an independent director candidate for a company listed on the Beijing Stock Exchange. It contains detailed personal qualifications, compliance with regulatory requirements, and commitments related to the independent director role. There are no financial statements, earnings data, or report summaries. The document is a formal announcement related to board/management information, specifically about a director candidate's declaration and qualifications. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is short and does not indicate it is a report or announcement of a report publication, so it is not RPA or RNS.
2023-12-10 Chinese
内部控制制度
Governance Information Classification · 95% confidence The document is titled '内部控制制度' (Internal Control System) and is issued by the company's board of directors. It details the internal control policies, risk assessment, internal control activities, management of subsidiaries, fundraising usage, related party transactions, external guarantees, major investments, information disclosure, communication, and internal supervision. The document includes detailed governance and control procedures, responsibilities of the board, management, audit committee, and other departments. It is a comprehensive internal control policy document rather than a financial report or announcement. It is not an announcement of a report publication, nor a certification or a brief notice. It is a governance-related document detailing internal rules and governance practices. Therefore, the most appropriate classification is Governance Information (CGR). The document length (over 10,000 characters) and detailed content support this classification with high confidence.
2023-12-10 Chinese
第三届监事会第二十三次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Sichuan Zitonggong Pharmaceutical Co., Ltd. It details the convening and attendance of the meeting, the proposals reviewed and approved, including the nomination of new supervisory board members, capital increase in a subsidiary, and reappointment of the audit firm. The document is a formal announcement of board/management decisions and changes, specifically related to the supervisory board and audit firm reappointment. It does not contain financial statements or detailed financial data, nor is it a report or transcript. It is not an announcement of voting results at a shareholder meeting but rather a board meeting resolution. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is short (1807 characters), consistent with a meeting resolution announcement rather than a full report.
2023-12-10 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.